Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Edema Secondary to Retinal Vein Occlusion”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Post-approval studies (Phase 4)Study completedNCT02953938
What this trial is testing

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Novartis Pharmaceuticals 59
Not applicableStudy completedNCT01442064
What this trial is testing

An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Genentech, Inc. 608
Post-approval studies (Phase 4)Study completedNCT00682240
What this trial is testing

Morphological and Functional Retinal Changes Following Retinal Photocoagulation

Who this might be right for
Proliferative Diabetic RetinopathyMacular Edema
Medical University of Vienna 64
Post-approval studies (Phase 4)Ended earlyNCT00566761
What this trial is testing

Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Asociación para Evitar la Ceguera en México 10
Testing effectiveness (Phase 2)UnknownNCT01123564
What this trial is testing

Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Edema
University of Pecs 40
Large-scale testing (Phase 3)Study completedNCT01012973
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Retinal Vein Occlusion
Bayer 177
Post-approval studies (Phase 4)UnknownNCT03892434
What this trial is testing

Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO

Who this might be right for
Branch Retinal Vein Occlusion With Macular Edema
Yeungnam University College of Medicine 40
Testing effectiveness (Phase 2)Study completedNCT06176963
What this trial is testing

Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO

Who this might be right for
Neovascular Age-related Macular DegenerationMacular EdemaRetinal Vein Occlusion
Samsung Bioepis Co., Ltd. 34
Not applicableUnknownNCT01581151
What this trial is testing

Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Brian Burke, MPH 30
Large-scale testing (Phase 3)UnknownNCT04460001
What this trial is testing

Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)

Who this might be right for
Ophthalmopathy
Assiut University 100
Testing effectiveness (Phase 2)Study completedNCT01724554
What this trial is testing

Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion

Who this might be right for
Central Retinal Vein OcclusionProliferative Diabetic Retinopathy
Ophthalmic Consultants of Boston 24
Large-scale testing (Phase 3)UnknownNCT03391219
What this trial is testing

Combined Intravitreal Injection of Bevacizumab and Fasudil Versus Bevacizumab Alone for Macular Edema Secondary to Retinal Vein Occlusion in Previously Treated Patients

Who this might be right for
Retinal Vein Occlusion
Shahid Beheshti University of Medical Sciences 36
Post-approval studies (Phase 4)Ended earlyNCT01795209
What this trial is testing

Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision

Who this might be right for
Branch Retinal Vein OcclusionMacular Edema
Seoul National University Bundang Hospital 19
Large-scale testing (Phase 3)Study completedNCT05520177
What this trial is testing

A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss

Who this might be right for
Branch Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 351
Not applicableStudy completedNCT02556723
What this trial is testing

Intravitreal Injections of Ziv-aflibercept for Macular Diseases

Who this might be right for
Diabetic Macular EdemaAge Related Macular DegenerationBranch Retinal Vein Occlusion With Macular Edema+1 more
Retina Clinic, Sao Paulo, Brazil 60
Large-scale testing (Phase 3)Study completedNCT03223714
What this trial is testing

Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Chengdu Kanghong Biotech Co., Ltd. 242
Large-scale testing (Phase 3)Study completedNCT00485836
What this trial is testing

The Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Genentech, Inc. 392
Testing effectiveness (Phase 2)Study completedNCT01662518
What this trial is testing

DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Centro de Pesquisa Rubens Siqueira 10
Not applicableStudy completedNCT01219205
What this trial is testing

Major and Macular Branched Retinal Venous Occlusion

Who this might be right for
Macular Edema
Hallym University Medical Center 46
Large-scale testing (Phase 3)Study completedNCT04740905
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Macular EdemaBranch Retinal Vein Occlusion
Hoffmann-La Roche 553
Load More Results